West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation

Trial StartChoICEPositive

AI Analysis

Summary

West Cancer Center received IRB approval to initiate IceCure Medical's ChoICE post-marketing study for breast cancer cryoablation, with patient enrollment expected to commence in the coming weeks.

Clinical Trial Data

Outcome Details

IRB approval received for ChoICE post-marketing study

Importance:5/10

Sentiment:

0.60

IRB approvalclinical trialcryoablationbreast cancerpost-marketing study

Related Companies

$ICCM

Read the original article

Published by PR Newswire Biotech on August 20, 2026 12:10 PM

Read Original